-Joel S Karliner Researcher Activity Profile

Research Author Detailed Information 

Joel S Karliner Publication Rate By Year

Joel S Karliner has published 3 paper(s) in 2006, 18 paper(s) in 2007, 2 paper(s) in 2008, for a total of 23 research publications in total.

Joel S Js Karliner Author Information

LAST NAME: karliner

FIRST NAME: Joel S

INITIALS: js

AFFILIATION:

Papers

Joel S Karliner's Publication Record

1. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Year Published: 2007
Department of Medicine, San Francisco Department of Veterans Affairs Medical Center/University of California, San Francisco, California 94121, USA.
2. Ischemic preconditioning depends on age and gender. Year Published: 2006
University of California, San Francisco, VA Medical Center, Cardiology Division 111C, 4150 Clement St, San Francisco, CA 94121, USA.
3. Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism. Year Published: 2006
Cardiology Section, VA Medical Center and Department of Medicine, University of California, San Francisco, CA 94121, USA.
4. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Year Published: 2006
Liver Study Unit, Department of Veterans Affairs Medical Center San Francisco CA 94121, USA. donald.vessey@med.va.gov
5. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes. Year Published: 2007
Cardiology Section, Veterans Affairs Medical Center, University of California, San Francisco, CA 94121, USA.
6. Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart. Year Published: 2007
Liver Study Unit, Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA. donald.vessey@med.va.gov
7. Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction. Year Published: 2007
Cardiology Section, Department of Medicine, UCSF, VA Medical Center, 4150 Clement Street, 111C-5, San Francisco, CA 94121, USA.
8. Adult cardiac fibroblasts null for sphingosine kinase-1 exhibit growth dysregulation and an enhanced proinflammatory response. Year Published: 2007
Cardiology Research, Cardiology Section (111C5), VA Medical Center, San Francisco, CA 94121, USA.
9. Epinephrine is required for normal cardiovascular responses to stress in the phenylethanolamine N-methyltransferase knockout mouse. Year Published: 2007
Department of Medicine, University of California San Diego, USA. xbao@ucsd.edu
10. Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stress. Year Published: 2007
Cardiology Division, University of California, San Francisco, USA.
11. A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury. Year Published: 2007
Cardiology Section, VA Medical Center and University of California, San Francisco, CA 94121, USA.
12. Redox-dependent change of nucleotide affinity to the active site of the mammalian complex I. Year Published: 2007
Department of Biochemistry, School of Biology, Moscow State University, Moscow 119992, Russian Federation.
13. Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes. Year Published: 2007
Cardiology Section, San Francisco VA Medical Center and UCSF, San Francisco, CA, USA.
14. Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart. Year Published: 2007
Liver Study Unit, Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA. donald.vessey@med.va.gov
15. Differences among cell types in NAD(+) compartmentalization: A comparison of neurons, astrocytes, and cardiac myocytes. Year Published: 2007
Neurology Service, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, California.
16. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Year Published: 2007
Medical Service and Cardiology Section, Veterans Affairs Medical Center, San Francisco, CA, USA.
17. Differences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes. Year Published: 2007
Neurology Service, Veterans Affairs Medical Center, 127 Neurology, San Francisco, CA 94121, USA. conrad.alano@ucsf.edu
18. Redox-dependent change of nucleotide affinity to the active site of the mammalian complex I. Year Published: 2007
Department of Biochemistry, School of Biology, Moscow State University, Moscow 119992, Russian Federation.
19. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Year Published: 2007
Medical Service and Cardiology Section, Veterans Affairs Medical Center, San Francisco, CA, USA.
20. Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy. Year Published: 2008
Univ. of California, San Francisco, VA Medical Center, Cardiology Division (111C 4150 Clement St., San Francisco, CA 94121. anthony.baker@ucsf.edu).
21. Differences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes. Year Published: 2007
Neurology Service, Veterans Affairs Medical Center, 127 Neurology, San Francisco, CA 94121, USA. conrad.alano@ucsf.edu
22. Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy. Year Published: 2008
VA Medical Center, Cardiology Division (111C ), University of California-San Francisco, 4150 Clement St., San Francisco, CA 94121, USA.
23. Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart. Year Published: 2007
Liver Study Unit, Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA. donald.vessey@med.va.gov